• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于减轻新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关注变体影响的抗菌和抗病毒高性能纳米系统。

Antibacterial and antiviral high-performance nanosystems to mitigate new SARS-CoV-2 variants of concern.

作者信息

Tiwari Shivani, Juneja Subhavna, Ghosal Anujit, Bandara Nandika, Khan Raju, Wallen Scott L, Ramakrishna Seeram, Kaushik Ajeet

机构信息

Department of Zoology, Delhi University, New Delhi, 110007, India.

NanoBiotechnology Lab, School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067, India.

出版信息

Curr Opin Biomed Eng. 2022 Mar;21:100363. doi: 10.1016/j.cobme.2021.100363. Epub 2021 Dec 1.

DOI:10.1016/j.cobme.2021.100363
PMID:34869963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8632437/
Abstract

The increased severity of the COVID-19 infection due to new SARS-CoV-2 variants has resonated pandemic impact which made health experts to re-evaluate the effectiveness of pandemic management strategies. This becomes critical owing to the infection in large population and shortcomings in the existing global healthcare system worldwide. The designing of high-performance nanosystems (NS) with tunable performances seems to be the most efficient method to tackle infectious SARS-CoV-2 variants including recently emerged omicron mutation. In this direction, experts projects the versatile functionalized NS and their capabilities to mitigate SARS-CoV-2 propagation pathways by sensitization, antipathogenicity, photocatalysis, photothermal effects, immune response, developing efficient diagnostics assays or associated, selective biomarkers detection, and targeted drug delivery systems. To achieve these tasks, this opinion article project the importance of the fabrication of nano-enabled protective gear, masks, gloves, sheets, filtration units, nano-emulsified disinfectants, antiviral/bacterial paints, and therangostics to facilitate quarantine strategies via protection, detection, and treatment needed to manage COVID-19 pandemic in personalized manners. These functional protective high-performance antibacterial and antiviral NS can efficiently tackle the SARS-CoV-2 variants transmission through respiratory fluids and pollutants within water droplets, aerosols, air, and particulates along with their severe infection via neutralizing or eradicating the virus.

摘要

新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体导致的新冠病毒疾病(COVID-19)感染严重程度增加,引发了大流行影响,促使健康专家重新评估大流行管理策略的有效性。鉴于全球大量人口感染以及现有全球医疗体系的缺陷,这一点变得至关重要。设计具有可调性能的高性能纳米系统(NS)似乎是应对包括最近出现的奥密克戎变异株在内的传染性SARS-CoV-2变体的最有效方法。在这一方向上,专家们设想了多功能功能化纳米系统及其通过致敏、抗致病性、光催化、光热效应、免疫反应、开发高效诊断检测方法或相关的选择性生物标志物检测以及靶向给药系统来减轻SARS-CoV-2传播途径的能力。为了完成这些任务,这篇观点文章设想了制造纳米防护装备、口罩、手套、床单、过滤装置、纳米乳化消毒剂、抗病毒/抗菌涂料以及治疗诊断学的重要性,以通过个性化管理COVID-19大流行所需的保护、检测和治疗来促进隔离策略。这些功能性防护高性能抗菌和抗病毒纳米系统可以通过中和或根除病毒,有效应对SARS-CoV-2变体通过呼吸道分泌物以及水滴、气溶胶、空气和颗粒物中的污染物传播及其严重感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e920/8632437/69b3d8a86e59/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e920/8632437/203b391fe02e/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e920/8632437/bf17bf841c50/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e920/8632437/680da27e8951/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e920/8632437/69b3d8a86e59/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e920/8632437/203b391fe02e/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e920/8632437/bf17bf841c50/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e920/8632437/680da27e8951/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e920/8632437/69b3d8a86e59/gr3_lrg.jpg

相似文献

1
Antibacterial and antiviral high-performance nanosystems to mitigate new SARS-CoV-2 variants of concern.用于减轻新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关注变体影响的抗菌和抗病毒高性能纳米系统。
Curr Opin Biomed Eng. 2022 Mar;21:100363. doi: 10.1016/j.cobme.2021.100363. Epub 2021 Dec 1.
2
Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations (Archived)针对轻度至中度症状的高危冠状病毒(COVID-19)患者的单克隆抗体疗法(存档)
3
Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects.纳米医学在 SARS-CoV-2 中的应用:现状与未来展望。
Int J Nanomedicine. 2021 Jan 22;16:539-560. doi: 10.2147/IJN.S283686. eCollection 2021.
4
SARS-CoV-2 Omicron variant: A next phase of the COVID-19 pandemic and a call to arms for system sciences and precision medicine.严重急性呼吸综合征冠状病毒2型奥密克戎变种:新冠疫情的新阶段以及对系统科学和精准医学的战斗号召。
MedComm (2020). 2022 Feb 11;3(1):e119. doi: 10.1002/mco2.119. eCollection 2022 Mar.
5
Electrochemical SARS-CoV-2 Sensing at Point-of-Care and Artificial Intelligence for Intelligent COVID-19 Management.用于即时护理的电化学新冠病毒刺突蛋白传感及用于智能新冠疫情管理的人工智能
ACS Appl Bio Mater. 2020 Nov 16;3(11):7306-7325. doi: 10.1021/acsabm.0c01004. Epub 2020 Oct 27.
6
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
7
Evaluating And Referring Patients For Outpatient Monoclonal Antibody Therapy For Coronavirus In The Emergency Department (Archived)在急诊科评估并转诊患者接受冠状病毒门诊单克隆抗体治疗(存档)
8
[Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].[氯丙嗪在新冠病毒肺炎治疗中的重新应用:恢复研究]
Encephale. 2020 Jun;46(3S):S35-S39. doi: 10.1016/j.encep.2020.04.010. Epub 2020 Apr 29.
9
Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum.新型冠状病毒肺炎进展:康复期血清中和抗体的持久性、有效性及免疫逃逸
Pathogens. 2022 Dec 13;11(12):1531. doi: 10.3390/pathogens11121531.
10
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19.下一代治疗方法:针对新冠病毒的免疫疗法和先进疗法。
Heliyon. 2024 Feb 19;10(5):e26423. doi: 10.1016/j.heliyon.2024.e26423. eCollection 2024 Mar 15.

引用本文的文献

1
State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic.用于突变型冠状病毒感染管理的前沿高性能纳米系统:从实验室到临床。
OpenNano. 2022 Nov-Dec;8:100078. doi: 10.1016/j.onano.2022.100078. Epub 2022 Sep 10.
2
Total Bio-Based Material for Drug Delivery and Iron Chelation to Fight Cancer through Antimicrobial Activity.用于药物递送和铁螯合以通过抗菌活性对抗癌症的全生物基材料
Nanomaterials (Basel). 2023 Jul 10;13(14):2036. doi: 10.3390/nano13142036.
3
Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness.

本文引用的文献

1
Electrochemical SARS-CoV-2 Sensing at Point-of-Care and Artificial Intelligence for Intelligent COVID-19 Management.用于即时护理的电化学新冠病毒刺突蛋白传感及用于智能新冠疫情管理的人工智能
ACS Appl Bio Mater. 2020 Nov 16;3(11):7306-7325. doi: 10.1021/acsabm.0c01004. Epub 2020 Oct 27.
2
Ultrasensitive and Reusable Graphene Oxide-Modified Double-Interdigitated Capacitive (DIDC) Sensing Chip for Detecting SARS-CoV-2.用于检测 SARS-CoV-2 的超灵敏可重复使用的氧化石墨烯修饰的双交错式电容(DIDC)传感芯片。
ACS Sens. 2021 Sep 24;6(9):3468-3476. doi: 10.1021/acssensors.1c01437. Epub 2021 Sep 3.
3
Lipid nanoparticles for mRNA delivery.
基于纳米的技术:一种预防新冠病毒和提高人类认知的革命性方法。
J Drug Deliv Sci Technol. 2023 Sep;86:104567. doi: 10.1016/j.jddst.2023.104567. Epub 2023 May 14.
4
COVID-19 associated thyroid dysfunction and other comorbidities and its management using phytochemical-based therapeutics: a natural way.COVID-19 相关甲状腺功能障碍及其他合并症及其基于植物化学物质的治疗管理:一种自然途径。
Biosci Rep. 2023 Jul 26;43(7). doi: 10.1042/BSR20230293.
5
Mitigation of SARS-CoV-2 by Using Transition Metal Nanozeolites and Quaternary Ammonium Compounds as Antiviral Agents in Suspensions and Soft Fabric Materials.使用过渡金属纳米沸石和季铵化合物作为悬浮液和软织物材料中的抗病毒剂来减轻 SARS-CoV-2 的影响。
Int J Nanomedicine. 2023 May 3;18:2307-2324. doi: 10.2147/IJN.S396669. eCollection 2023.
6
Antiviral Lipid Nanocarrier Loaded with Remdesivir Effective Against SARS-CoV-2 in vitro Model.载有瑞德西韦的抗病毒脂质纳米载体在体外模型中对 SARS-CoV-2 有效。
Int J Nanomedicine. 2023 Mar 27;18:1561-1575. doi: 10.2147/IJN.S391462. eCollection 2023.
7
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status.基于腺病毒载体的COVID-19疫苗平台:现状
Vaccines (Basel). 2023 Feb 13;11(2):432. doi: 10.3390/vaccines11020432.
8
Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications.用于新冠疫苗开发的纳米技术及其递送应用的各个方面。
Pharmaceutics. 2023 Jan 30;15(2):451. doi: 10.3390/pharmaceutics15020451.
9
Role of Wearable Sensing Technology to Manage Long COVID.可穿戴传感技术在管理长新冠中的作用。
Biosensors (Basel). 2022 Dec 31;13(1):62. doi: 10.3390/bios13010062.
10
Recent Advances in Biosensors for Detection of COVID-19 and Other Viruses.用于检测 COVID-19 和其他病毒的生物传感器的最新进展。
IEEE Rev Biomed Eng. 2023;16:22-37. doi: 10.1109/RBME.2022.3212038. Epub 2023 Jan 5.
用于mRNA递送的脂质纳米颗粒。
Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10.
4
Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents.无生命表面在冠状病毒传播中的潜在作用及其被消毒剂灭活的情况。
Infect Prev Pract. 2020 Jun;2(2):100044. doi: 10.1016/j.infpip.2020.100044. Epub 2020 Feb 12.
5
The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy.新型冠状病毒病发病机制的分子基础、常规药物和纳米医学治疗。
Int J Mol Sci. 2021 May 21;22(11):5438. doi: 10.3390/ijms22115438.
6
High-performance antiviral nano-systems as a shield to inhibit viral infections: SARS-CoV-2 as a model case study.高性能抗病毒纳米系统作为抑制病毒感染的屏障:以 SARS-CoV-2 为例进行研究。
J Mater Chem B. 2021 Jun 16;9(23):4620-4642. doi: 10.1039/d1tb00472g.
7
Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside.基于纳米的 COVID-19 诊断和治疗平台:从实验台到病床。
ACS Biomater Sci Eng. 2021 Jun 14;7(6):2150-2176. doi: 10.1021/acsbiomaterials.1c00318. Epub 2021 May 12.
8
Will SARS-CoV-2 variants of concern affect the promise of vaccines?高关注变异株会影响疫苗的效果吗?
Nat Rev Immunol. 2021 Jun;21(6):340-341. doi: 10.1038/s41577-021-00556-5.
9
Manipulation of genes could inhibit SARS-CoV-2 infection that causes COVID-19 pandemics.基因操纵可以抑制导致 COVID-19 大流行的 SARS-CoV-2 感染。
Exp Biol Med (Maywood). 2021 Jul;246(14):1643-1649. doi: 10.1177/15353702211008106. Epub 2021 Apr 25.
10
Role of nanotechnology behind the success of mRNA vaccines for COVID-19.纳米技术在COVID-19 mRNA疫苗成功背后的作用。
Nano Today. 2021 Jun;38:101142. doi: 10.1016/j.nantod.2021.101142. Epub 2021 Mar 26.